Inflammatory Bowel Disease CD19+ B Cells
About: Inflammatory Bowel Disease CD19+ B Cells are isolated from IRB-consented donors with clinically confirmed IBD. Ideal for investigating B cell-mediated autoantibody production and mucosal immune dysregulation.
Inflammatory Bowel Disease CD19+ B Cells for Autoimmune Research
Inflammatory Bowel Disease (IBD) CD19+ B Cells are cryopreserved from peripheral blood of IRB-consented adult donors diagnosed with Inflammatory Bowel Disease. These CD19+ B cells reflect disease-associated immune alterations and offer a critical resource for studying autoantibody production, B cell activation, and mucosal humoral immunity in the context of IBD.
Product Features
- Research Use Only (RUO), CD19+ enriched B cells
- Isolated from clinically diagnosed IBD donors
- High viability and enrichment
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- Ethically sourced with IRB approval and HIPAA compliance
De-identified Donor Data
- Confirmed diagnosis of Inflammatory Bowel Disease
- Demographics: age, sex assigned at birth, race/ethnicity
- Self-reported clinical history and medication use
Applications
- Investigation of B cell phenotypes and function in IBD
- Autoantibody and mucosal immunity studies
- Disease mechanism studies and biomarker identification
- Preclinical immunotherapy development
Compliance and Quality Assurance
- IRB-approved collection and 21 CFR Part 11-compliant e-consent
- Standardized processing and quality protocols
- HIPAA-compliant data handling
Ordering & Customization
Inflammatory Bowel Disease CD19+ B Cells are offered in standard or custom aliquot sizes. For regulatory documentation or international support, contact learnmore@sanguinebio.com.
Protocols & Documentation
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
CD19+ B Cells
Frequently Asked Questions
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – All three cell types are available.
Ask a Question
Need a custom CD19+ B Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.